Matinas BioPharma Reports Second Quarter 2018 Financial Results and Provides Corporate Update

World News: . []

BEDMINSTER NJ Aug 10 2018 GLOBE NEWSWIRE -- NYSE AMER MTNB a clinical-stage biopharmaceutical company focused on enabling targeted intracellular delivery of life-changing medicines using its proprietary lipid nano-crystal LNC platfo rm tech...

More news and information about Matinas BioPharma Holdings, Inc.

Published By:

Globe Newswire: 13:15 GMT Friday 10th August 2018

Published: .

Search for other references to "matinas" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us